FOR IMMEDIATE RELEASE
Asthma Treatment, RSV Risk Prediction Tool, Clinical Trial Results in Pulmonary Medicine & More at ATS 2024 International Conference
NEW YORK, NY - May 13, 2024 – With the ATS 2024 International Conference only days away, register now to fast-track your conference news coverage. Here are some of the research abstracts that will be presented. They were selected by the International Conference Committee, which reviews all submissions and extracts a small number of especially newsworthy research.
Please note: all abstracts are embargoed until the time of presentation at the ATS 2024 International Conference.
- EX-CIGARETTE SMOKERS WHO VAPE MAY BE AT HIGHER RISK FOR LUNG CANCER
- EXTREME HEAT ASSOCIATED WITH CHILDREN’S ASTHMA HOSPITAL VISITS
- FEW MODERATE OR SEVERE ASTHMA PATIENTS PRESCRIBED RECOMMENDED INHALER REGIMEN [Listen to Q & A]
- HORMONE REPLACEMENT THERAPY (HRT) MAY IMPROVE PULMONARY HYPERTENSION AND RIGHT VENTRICULAR FUNCTION
- HOSPITALS CARING FOR DIVERSE PATIENT POPULATIONS HAVE HIGHER MECHANICAL VENTILATION MORTALITY
- NEW TOOL MAY HELP PRIORITIZE HIGH-RISK INFANTS FOR RSV IMMUNIZATION [Listen to Q & A]
- PARC MODEL OF CARE ASSOCIATED WITH FEWER DEATHS AMONG VETERANS POST-ICU
- POOR ACCESS TO IN-HOME NURSING FOR MEDICALLY COMPLEX CHILDREN QUANTIFIED
- SPIROMETRY CLINICAL TRIAL ELIGIBILITY MAY DIFFER WITH RACE-NEUTRAL EQUATIONS
One of the most highly anticipated learning opportunities at ATS 2024, the Scientific Symposium, "Breaking News: Clinical Trial Results in Pulmonary Medicine," will focus on newly available trials with the potential for great clinical impact. All speakers will be presenting their results for the first time in an open public forum. Learn more.
Download the ATS 2024 conference app now. For an enhanced user experience, visit our new platform - ATS 2024 (d365.events) - to browse the program and abstracts as well as use the chat function.
To arrange an interview with an ATS subject matter expert or conference speaker, contact Dacia Morris at dmorris@thoracic.org.
###